4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
InterCure Ltd. (INCR) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Herzliya, Israel with about 285 employees. Its market capitalization is roughly $55 million. In the fiscal year ended 2025-12-31, INCR reported $270M in revenue and ($36M) in net income.
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $270M | $239M | $356M | $389M | — |
| Gross Profit | $33M | $30M | $105M | $155M | — |
| Operating Income (EBIT) | $7M | ($45M) | $38M | $41M | — |
| Net Income | ($36M) | ($68M) | ($62M) | $45M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | $0M | $0M | $0M | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $691M | $763M | $787M | $958M | — |
| Total Liabilities | $294M | $365M | $330M | $436M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive INCR viewer.
About TickerBase · Data methodology & sources